FDA approves Gelesis prescription weight-loss drug Plenity for adults
Category: #health  By Mateen Dalal  Date: 2019-04-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA approves Gelesis  prescription weight-loss drug Plenity for adults

Plenity is has been cleared for obese or overweight adults having a body mass index of at least 25

Reports confirm that the U.S. Food and Drug Administration (FDA) has recently granted approval to an innovative prescription drug aimed at helping with weight loss and weight management.

The drug has reportedly been developed by Gelesis and is called Plenity, now cleared for obese or overweight adults having a body mass index of at least 25, even if they might not suffer from other health conditions. It has to be utilized in combination with exercise and diet, besides being suitable for consumption with other weight-loss medications as well, FDA informed.

Dr. Caroline Apovian, the director of nutrition and weight management at Boston Medical Center and who was able to study Plenity in the research sponsored by Gelesis, said that this was a remarkable approval by the FDA. Apparently, most of the weight-loss treatment options are meant for patients having BMI of 30 or above, or those suffering other health issues associated with weight.

Citing reliable sources, the FDA has given approval to only five prescription weight-loss drugs apart from Plenity, in addition to continuously warning consumers against products claiming to deliver miraculous weight loss.

Weight-loss drugs approved earlier usually worked by targeting the brain for suppressing appetite or simulate the feeling of a full stomach. In contrast, Plenity is aimed at filling the stomach when consumed before a meal, sources mentioned.

Supposedly, a mixture of citric acid and cellulose in each pill expands to form a hydrogel, when hydrated within the stomach, having the consistency of chewed food. The gel, claimed to fill quarter of a stomach without adding calories, can pass through the digestive system like regular food.

According to Gelesis, people lost an average 10% of their body weight within six months using Plenity. One Gelesis-sponsored trial found that people taking Plenity exhibited twice the probability of losing 5% or 10% of their body weight across six months, in comparison to people taking a placebo.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Chloromethane Market Size to gain remarkable traction from personal care applications
Chloromethane Market Size to gain remarkable traction from personal care applications
By Mateen Dalal

Chloromethane market report provides a comprehensive landscape of the industry, accurate market estimates and forecast split by product, application, technology, region and end-use. All quantitative information is covered on a regional as well as cou...

Athira Pharma presents initial results from phase 1 trial of NDX-1017
Athira Pharma presents initial results from phase 1 trial of NDX-1017
By Mateen Dalal

The company has been looking forward to initiate larger phase 2 trials. The clinical-stage company Athira Pharma, Inc. has reportedly announced preliminary data from the phase 1 clinical trial of its lead therapeutic molecule, NDX-1017, at the Alzhe...

McDonald’s announces partnership with DoorDash for McDelivery services
McDonald’s announces partnership with DoorDash for McDelivery services
By Mateen Dalal

McDonalds, the American fast food chain, recently announced expansion of its delivery options with inclusion of a new delivery partner, DoorDash and has ended its exclusive partnership with UberEats, cite sources. For the record, since 2017, UberEat...